Answers are grounded in this paper and cite their sources.
Highlights the risk of anaphylactoid reactions during LDL apheresis with dextran sulphate adsorption in patients taking ACE inhibitors, with implications for ARB use.
Anaphylactoid reactions during low-density lipoprotein (LDL) apheresis with dextran sulphate adsorption have been reported in patients taking angiotensin converting enzyme (ACE) inhibitors.
No takes yet. Share an insight, caveat, or question.
Elicio et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: